FibroBiologics Corp (FBLG): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand FibroBiologics, Inc. (FBLG)

FibroBiologics, Inc. (FBLG) is implementing environmental ESG standards and strict bioethical norms within its laboratories. The price-to-sales ratio visualizes the deviation of quotes from fundamental indicators, where captures the magnitude of this parameter. The company is diversifying risks by studying fibroblasts to combat cancer, aiming to secure a leading position in tissue regeneration backed by robust patent protection.

FBLG FibroBiologics P/S Multiple (07/04/2022 - 11/13/2026)

Metric breakdowns and analytics for FibroBiologics, Inc. (FBLG)

- current price and projected stock value:
Price Chart fibrobiologics.com|FBLG - Price Target Chart
- stock exchange capitalization data:
Market Value FibroBiologics Corp|FBLG - Total Company Value
- book capitalization indicators:
Net Asset Value per Share FibroBiologics|FBLG - Book Capitalization|Market Value to Book Value Ratio fibrobiologics.com|FBLG - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Coefficient FibroBiologics, Inc.|FBLG - Long-Term Debt to Equity|Current Liabilities to Capital fibrobiologics.com|FBLG - Company Debts|Debt to Book Capitalization Ratio FibroBiologics Corp|FBLG - Company Long-Term Debt|Short-Term Debt FibroBiologics|Critical Liquidity fibrobiologics.com
- earnings and multiples data:
FBLG - Net Profit|Company Profit Forecast FibroBiologics, Inc.|FBLG - P/E Multiple|Projected Price to Earnings fibrobiologics.com|FBLG - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio FibroBiologics Corp|FBLG - Operating profit before deduction of amortization|Earnings per share for the trailing year FibroBiologics|FBLG - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months fibrobiologics.com|FBLG - Earnings per share growth in current year|Projected earnings per share growth rate for next year FibroBiologics, Inc.
- issuer revenue and sales details:
FBLG - Revenue and Sales Volume|Company Future Sales Volume fibrobiologics.com|FBLG - Market Cap to Revenue|Market Cap to Expected Sales Ratio FibroBiologics Corp
Fundamental company analysis:FibroBiologics Inc. FBLG
Core merchandise of FibroBiologics Corp

The automation of stem cell production according to GMP standards at FibroBiologics, Inc. minimizes human error, impacting future operational efficiency. The price-to-sales ratio compares market capitalization to sales volume, measuring the premium the market is willing to pay per unit of revenue. The price action of this price-to-sales valuation reveals whether the asset is overvalued or undervalued relative to its current cash flows. This allows an investor to determine the company's fair cost of capital.

Competitors of FibroBiologics, Inc.

Price-to-Revenue Ratio MESO (mesoblast.com)|Price-to-Revenue Ratio Lineage Cell Therapeutics, Inc. LCTX|Market Capitalization-to-Revenue Ratio SRZN|CCEL - Price-to-Revenue Ratio|Price to Sales Longeveron Corporation|BRTX: P/S Multiple|CELZ (Creative Medical Technology Holdings) - Price-to-Revenue Ratio